ArticleBone marrow transplantation2022
Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
Zixuan Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it